Emmerich Ilka Ute
Dr. Ilka Ute Emmerich, VETIDATA, Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät, Universität Leipzig, An den Tierkliniken 39, 04103 Leipzig, E-Mail:
Tierarztl Prax Ausg G Grosstiere Nutztiere. 2016 Jun 16;44(3):164-70. doi: 10.15653/TPG-160400. Epub 2016 May 24.
In 2015, four newly developed active pharmaceutical ingredients for horses and food-producing animals were released on the German market for veterinary drug products. These were the bisphosphonate Clodronic Acid (Osphos®), the 5-hydroxytryptamine (2A) receptor antagonist Ketanserin (Vulketan®), the aminoglycoside antibiotic Paromomycin (Parofor®) and the antibiotic Thiamphenicol (TAF Spray®) from the fenicole group. With Chlorphenamine, a temporary not available active ingredient was reapproved in a new drug. Furthermore, three veterinary drugs with a new formulation as well as one product with a new strength and two products with a new combination of active pharmaceutical ingredients have been launched.
2015年，四种新开发的用于马匹和食用动物的活性药物成分在德国市场上作为兽药产品上市。它们分别是双膦酸盐氯膦酸（Osphos®）、5-羟色胺（2A）受体拮抗剂酮色林（Vulketan®）、氨基糖苷类抗生素巴龙霉素（Parofor®）以及非尼可类抗生素甲砜霉素（TAF Spray®）。氯苯那敏作为一种暂时无法获取的活性成分，在一种新药中重新获批。此外，还推出了三种具有新剂型的兽药、一种具有新规格的产品以及两种具有新活性药物成分组合的产品。
